A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

NCT02252640 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

BIOLOGICAL: RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)
BIOLOGICAL: RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01)
BIOLOGICAL: ChAd63 ME-TRAP (5 x 10^10 vp)
BIOLOGICAL: MVA ME-TRAP (2 x 10^8 pfu)

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]